1Vallance P, Leone A, Calver A, et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet, 1992, 339:572- 575.
2Boger RH, Bode-Boger SM. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Semin Thromb Hemost, 2000, 26:539- 545.
3Boger RH, Bode-Boger SM, Tsao PS, et al. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol, 2000, 36:2287-2295.
4Ito A, Tsao PS, Adimoolam S, et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation, 1999, 99:3092-3095.
5Leiper J, Murray-Rust J, Mcdonald N, et al. dirnet hylarginine dimethylaminohydrolase S-nitrosylation of regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci U S A, 2002,99: 13527-13532.
6Ueda S, Kato S, Matsuoka H, et al. Regulation of cytokine- induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circ Res, 2003, 92,226-233.
7Nijveldt RJ, Teerlink T, Siroen MP, et al. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr, 2003, 22:17 -22.
8Ito A, Tsao PS, Adimoolam S, et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation,1999, 99:3092-3095.
9Nijveldt RJ, Teerlink T, Van Der Hoven B, et al. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr, 2003, 22:23-30.
10Lluch P, Torondel B, Medina P, et al. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis. J Hepatol, 2004, 41:55-59.
